QA: Edesa Biotech Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001540159_2018_Edesa_Biotech_Inc.pdf

Logs

warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': inf, 'aggregate_val': 211849, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}}

Graph

Absolute values for 0001540159, Edesa Biotech Inc

  xvar xval
0 AssetsCurrent 6,758,447
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 879,523
3 remainder_Assets 82,035
4 LiabilitiesCurrent 320,947
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 245,789
8 SellingGeneralAndAdministrativeExpense 2,892,604
9 ResearchAndDevelopmentExpense 1,888,660
10 remainder_Expenses 295,286
11 remainder_Revenues 500,472
12 remainder_NetIncome 53,979
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 7,720,005
1 Liabilities 320,947
2 Expenses 5,322,339
3 Revenues 500,472
4 StockholdersEquity 7,399,058
5 NetIncome -4,767,888
6 ComprehensiveNetIncome -4,767,888
7 BaseVar 6,958,871
8 EconomicCapitalRatiobeforeLimitedLiability 2.83
9 EconomicCapitalRatio 3.57

Edgar->Model Mapping

Feature Distribution

Change over Time